Medprime Technologies, a medical device company, announced the launch of Micalys, an AI-integrated digital microscopy platform in India.
According to a statement from the company, the key features of Micalys include:
- Whole slide imaging: Micalys allows for capturing the entire slide and viewing a complete and detailed representation of the specimen coupled with quick sharing options.
- Live view with robotic remote control: It provides a live view along with the capability to control the stage position, focus and magnification remotely.
- Manual microscopy: Micalys provides the features of a traditional digital microscope as well. It allows control of stage movement using a joystick and digital capturing of images and videos.
- AI-assisted diagnosis: Future ready to support all AI applications, it helps in the detection of various histological and cytological samples as well as blood smears.
In addition, the platform offers up to 100x Magnification with imaging at 20x, 40x, and 100x objectives available, has a user-friendly interface, and is more affordable than any existing single slide WSI system, informs the statement.
“Micalys has immense potential for malaria, filaria and TB screening in resource-limited areas. ML-based analysis algorithms can be used to assist in the diagnosis of these infections in the absence of trained technicians, thus addressing a critical gap in the current diagnostic landscape.” It adds that this device, “will empower pathologists to diagnose a range of conditions with greater precision, including filariasis, tuberculosis, and cancer in the future,” and informs that it has filed three patent applications with the Government of India, all of which have already been granted.
Medprime was founded by four biomedical engineering postgraduates from IIT Bombay in 2014. It is funded by the USAID-supported SAMRIDH fund, managed by IPE Global, as well as BIG and SBIRI grants from BIRAC.